2010
DOI: 10.1590/s0100-40422010000100030
|View full text |Cite
|
Sign up to set email alerts
|

Metabólitos secundários de origem vegetal: uma fonte potencial de fármacos antitrombóticos

Abstract: Cardiovascular diseases are responsible for the largest number of deaths among humans worldwide, including heart attacks, strokes, and thrombosis. The treatment of thrombosis is generally through the administration of anticoagulant and/or antiplatelet drugs, which have some clinical limitations. Plants synthesize a wide variety of bioactive metabolites in response to different stimuli. This review focuses on a number of molecules of vegetal origin belonging to different chemical classes, with significant antic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0
6

Year Published

2012
2012
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(14 citation statements)
references
References 51 publications
0
8
0
6
Order By: Relevance
“…To complement these findings, normal smears and those with addition of plant extracts were done (Figure 1). The use of antithrombotic plants could be an alternative to reduce the side effects from pharmaceutical products commonly used in thrombotic-related diseases (Chaves et al, 2010). At first an alcoholic extract was prepared which was more effective solvent for extracting secondary metabolites than aqueous extracts (Chandrasekaran and Venkatesalu, 2004).…”
Section: Resultsmentioning
confidence: 99%
“…To complement these findings, normal smears and those with addition of plant extracts were done (Figure 1). The use of antithrombotic plants could be an alternative to reduce the side effects from pharmaceutical products commonly used in thrombotic-related diseases (Chaves et al, 2010). At first an alcoholic extract was prepared which was more effective solvent for extracting secondary metabolites than aqueous extracts (Chandrasekaran and Venkatesalu, 2004).…”
Section: Resultsmentioning
confidence: 99%
“…Quantitative evaluation of the antioxidant activity of the crude extract and fractions was performed according to the methodology described by Chaves et al (2010). The radical consumption was monitored by the decrease of their absorbance Ultraviolet-visible spectroscopy (UV-VIS) spectrophotometer (UV BEL PHOTONICS 1105) at 515 nm, using glass cuvettes with 1 cm optical path.…”
Section: 1-diphenyl-2-picryl Hidrazyl (Dpph) Methodsmentioning
confidence: 99%
“…Em condições normais, a enzima EPSP catalisa, na planta, a reação que envolve a transferência do enolpiruvil do fosfoenolpiruvato (PEP) para o chiquimato-3-fosfato (S3P), formando 5-enolpiruvil-chiquimato-3-fosfato (EPSP) e fosfato inorgânico, Pi (Figura 4) (Coutinho & Mazo, 2005).…”
Section: Biossíntese Da Cumarinaunclassified
“…A varfarina (Figura 6, 12) cuja estrutura química resulta de uma modificação da cumarina (Figura 6, 13), é um anticoagulante oral que atua como inibidor da vitamina K, um cofator essencial para a síntese de fatores da coagulação II, VII, IX e X (Chaves et al, 2010). Outras moléculas com o esqueleto químico das cumarinas, como acenocumarol (Figura 6,14), femprocumona (Figura 6,15) e dicumarol (Figura 6,16), também apresentam atividade anticoagulante (Chaves et al, 2010).…”
Section: Interações Medicamentosas E Toxicidadeunclassified
See 1 more Smart Citation